Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Binia Maria Günther
    Member
    • Dec 2012
    • 24

    #1

    Next Generation Sequencing Technician / Technologist (m/f)

    To keep up with rapid growth at the Biomedical Sequencing Facility, we are hiring a Next Generation Sequencing Technician / Technologist to join our team. The successful candidate will operate the latest genome sequencing equipment and contribute to cutting-edge biomedical research and service provision for biomedical research and whole genome medicine. The Biomedical Sequencing Facility is Austria’s first and leading center of expertise for next generation sequencing in biomedicine. It is run as a joint endeavor of the Medical University of Vienna and the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences.

    The Candidate
    We are looking for highly motivated, well-organized, and hard-working candidates who feel comfortable working in a dynamic and demanding environment. The work involves handling a large number of collaborations and clients in parallel, thus requiring the ability to effectively multi-task, combined with stress resistance, high accuracy, friendliness and professional behavior, and a collaborative mindset. A typical candidate would have a Bachelor or Master degree in the life sciences and prior experience doing wet-lab work in a demanding environment. Candidates with a TA/MTA diploma or with a PhD will also be considered. Prior experience with next generation sequencing or DNA-based diagnostics is a plus (but not mandatory). Tasks and pay are commensurable with experience and skills. We take career development of our staff seriously at CeMM. For example, we will train the successful candidate in various state-of-the-art technologies that are in high demand in both academia and industry, and we encourage substantial contribution and co-authorship for publications in top journals. It is expected that genomic medicine will be an area of major growth in Austria and internationally (cf. Obama’s plan for a massive precision medicine initiative), thus creating a highly promising area for career development.

    Typical Tasks
    Running the sequencers. Operating the Illumina HiSeq/MiSeq sequencers on a routine basis at the best possible quality
    Library preparation. Preparing samples for genome, epigenome, and transcriptome sequencing (manually or using robotics)
    Collaborations and customer support. Interacting with researchers who send their samples for sequencing
    Troubleshooting. Detecting and resolving technical problems with the machines and with low-quality samples
    Protocol optimization. Establishing and testing new protocols, often in close collaboration with customers
    Lab management. Keeping track of samples and stocks, contributing to order management and service billing
    Training and outreach. Contributing to workshops and teaching collaborating scientists how to prepare their samples
    Genom Austria. Depending on interest, work with CeMM’s citizen science project on personal genomes could be part of the job


    The Biomedical Sequencing Facility (http://cemm.at/research/groups/biome...-facility-bsf/)
    The successful candidate will be part of the team of the Biomedical Sequencing Facility (BSF), which is based at CeMM. The BSF was Austria’s first (and is still the largest) technology platform and academic service provider dedicated to next generation sequencing in biomedicine. It is a non-commercial service unit jointly operated by the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Medical University of Vienna. Under the leadership of Christoph Bock and with a dedicated team of staff scientists, the BSF contributes to biomedical research and whole genome medicine in Vienna, Austria, and beyond (international clients include leading institutions such as Oxford and Cambridge University, the German Cancer Research Center, and the WHO International Agency for Research on Cancer). The BSF is equipped with several Illumina high-throughput sequencers (2x HiSeq 3000/4000 series, 2x HiSeq 2000 series), with the MiSeq and Oxford Nanopore platforms, and with a 96-well robotics platform that supports automated library preparation for genomes, epigenomes and transcriptomes. The computational infrastructure of the BSF comprises a scientific computing cluster that is upgraded annually to keep pace with steeply increasing amounts of data generation (current status: >100 CPUs, >1,000 cores, >10 TB memory, >1,000 TB storage). The BSF focuses on technologies with direct relevance to biomedicine and currently offers genome, epigenome and transcriptome sequencing services for biomedical research. Furthermore, it supports biomedical scientists and clinicians in the development of custom NGS protocols and in the bioinformatic analysis of the resulting datasets.

    The Institute (http://www.cemm.at)
    The CeMM Research Center for Molecular Medicine is an international and interdisciplinary research institute of the Austrian Academy of Sciences. Driven by medical needs, CeMM integrates basic research and medical expertise to pursue innovative diagnostic and therapeutic approaches focused on cancer, inflammation, and immune disorders. CeMM is located in a new building at the center of Vienna’s Medical University campus, within walking distance of Vienna’s historical city center. According to a study by “The Scientist”, CeMM is among the top-5 best places to work in academia world-wide (http://the-scientist.com/2012/08/01/...-academia-2012). Vienna is frequently ranked the world’s best city to live. It is a United Nations city with a large English-speaking community. The official language at CeMM is English, and more than 30 different nationalities are represented at the institute.

    Please apply online (https://prescreen.io/j/ljxswiy5) with cover letter, CV, academic transcripts, and contact details of 3 referees. Applications will be reviewed on a rolling basis starting now until the position is filled. Applications received after August 25th are unlikely to be considered.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Working...